Home » Newsletters » BioWorld Science

BioWorld Science

July 26, 2017

View Archived Issues

Genocea Biosciences announces topline data from phase IIb study of GEN-003

ALT-803 induces NK- and T-cell activation in SIV-infected macaques

GlaxoSmithKline submits sNDA to the FDA for Arnuity Ellipta in children with asthma

Serum 3-nitrotyrosine is a potential prediagnosis biomarker of postsurgery sepsis

Topline data reported from Novavax's phase II study of RSV F vaccine

Phase III study of Keytruda in HNSCC misses primary endpoint

Frontier Biotechnologies enters agreement with Rockefeller University

Aptevo and Alligator Bioscience to codevelop cancer immunotherapy

Ono Pharmaceutical presents promising in vitro and preclinical data for ONO-5450598

Flex Pharma's FLX-787 wins FDA fast track status for muscle cramps in ALS patients

Investigators in China patent MAPK 1 inhibitors

Asthma compounds identified at Sichuan Haisco Pharmaceutical

Karyopharm Therapeutics presents exportin-1 antagonists

UCB files for U.S. and E.U. approvals for Cimzia in moderate to severe chronic plaque psoriasis

Compounds for cancer discovered at Karyopharm Therapeutics

Axsome Therapeutics reports positive topline results from phase I study of AXS-06

Sernova provides update on regenerative medicine therapy for hemophilia A

FDA grants fast track designation to caplacizumab for acquired thrombotic thrombocytopenic purpura

Onconova Therapeutics enters agreements to advance rigosertib in pediatric RASopathies

Tetraphase reports topline results from IGNITE4 trial of eravacycline in cIAI

AntriaBio doses first patient in phase I study of AB-101

Santen initiates phase IIa study of DE-122 for wet AMD

The Medicines Co. provides update on TANGO-2 study of meropenem/vaborbactam

Phase III data for glecaprevir/pibrentasvir combination in HIV-1/HCV coinfected patients presented

Eisai seeks approval of lenvatinib for HCC in U.S. and E.U.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...